Sarilumab Plus Methotrexate in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate: Results of a Phase III Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sarilumab Plus Methotrexate in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate: Results of a Phase III Study

Published:2015-05-25 Issue:6 Volume:67 Page:1424-1437
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Genovese Mark C.¹,Fleischmann Roy²,Kivitz Alan J.³,Rell‐Bakalarska Maria⁴,Martincova Renata⁵,Fiore Stefano⁶,Rohane Patricia⁶,van Hoogstraten Hubert⁶,Garg Anju⁶,Fan Chunpeng⁶,van Adelsberg Janet⁷,Weinstein Steven P.⁷,Graham Neil M. H.⁷,Stahl Neil⁷,Yancopoulos George D.⁷,Huizinga Tom W. J.⁸,van der Heijde Désirée⁸

Affiliation:

1. Stanford University Medical CenterPalo Alto California

2. Metroplex Clinical Research CenterDallas Texas

3. Altoona Center for Clinical ResearchDuncansville Pennsylvania

4. Rheumatology and Osteoporosis Outpatient ClinicWarsaw Poland

5. SanofiPrague Czech Republic

6. Sanofi Bridgewater New Jersey

7. Regeneron Pharmaceuticals TarrytownNew York

8. Leiden University Medical CentreLeiden The Netherlands

Funder

Sanofi

Regeneron

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.39093

Reference46 articles.

1. Evolution of treatment for rheumatoid arthritis

2. 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

3. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

4. Radiographic imaging: the 'gold standard' for assessment of disease progression in rheumatoid arthritis

5. TNF inhibitors: new and old agents for rheumatoid arthritis;Simsek I.;Bull NYU Hosp Jt Dis,2010

Cited by 215 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolving role of immunology in chronic pain medicine: tissue necrosis factor and interleukin modulatory treatments;Exploration of Immunology;2024-08-28

2. Efficacy and safety of sarilumab in patients with rheumatoid arthritis stratified by age (<65 and ≥65 years): A post hoc analysis of Japanese Phase 3 clinical trials;Modern Rheumatology;2024-07-29

3. Efficacy and safety of first-line biological DMARDs in rheumatoid arthritis patients with chronic kidney disease;Annals of the Rheumatic Diseases;2024-07-04

4. Preclinical evaluation of ELP‐004 in mice;Pharmacology Research & Perspectives;2024-06-28

5. Safety of sarilumab in a Japanese population with rheumatoid arthritis by age group: Data from an interim analysis of a postmarketing surveillance study;Modern Rheumatology;2024-05-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3